Login
Toggle navigation
Videos
Categories
Trending
Lakehouse leads pre-seed rounds for companies focused on urgent problems founded by focussed operators|Will Berkowitz,Partner,Lakehouse Ventures
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Will is a partner at Lakehouse Ventures.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
James P. Scriven, CEO of IDB Invest, focuses on Latin American finance and development in collaboration with the International Finance Corporation.
00:10:00
Interview with James Baker of The Investment Company and David Horner of Chelverton Asset Management: Insights on Small Cap Dividend Investing | David Horner - Investment Trusts Director at Chelverton Asset Management Ltd
00:10:00
Trevor Rees-Jones: From Law to Oil & Gas Entrepreneurship
00:10:00
Sanjiv Kumar Singh, Director (Mining) at Hindustan Copper Limited, oversees mining operations and strategy for the company.|Shri Ghanshyam Sharma at Hindustan Copper Limited
00:10:00
Chart Industries CEO Jillian Evanko: Clean Energy Funding Insights | Jillian C. Evanko - CEO of Chart Industries, Inc.
00:10:00
Davenport Resources: Exploiting Potash Resources in Germany at One-to-One Mining Investment Conference
00:00:00
SQI Diagnostics (TSXV:SQD) Can Multiplex a Blood Test: CEO - Andrew Morris DIRECTOR AND CHIEF EXECUTIVE OFFICER, SQI Diagnostics Inc
00:00:00
Petter Bäckgren, CEO, Bioservo Technologies
00:10:00
Sondrel (Holdings) PLC's founder and CEO Graham Curren discusses the company's AIM listing with Proactive.
00:10:00
A Deep Dive into Real Estate Branding and Talent Development | Scott Durkin , CEO ,Douglas Elliman Inc.
00:10:00
Update on Alligator Bioscience's Clinical Trials and Pipeline Progress, Anticipating Positive Outcomes and Partnership Discussions |Søren Bregenholt, CEO, Alligator Bioscience AB.
00:10:00
Transitioning Investment Banking Strategies: Embracing Advisory Services and Diversification | C.S. Venkatakrishnan , CEO , Barclays.